JMJD6 and cancer: In most cancers, higher JMJD6 expression was associated with shorter OS in cases of adrenocortical carcinoma (ACC) (HR = 5.3, Logrank p = 0.017), esophageal carcinoma (ESCA) (HR = 2.1, Logrank p = 0.026), kidney renal clear cell carcinoma (KIRC) (HR = 2.4, Logrank p = 0.00015), kidney renal papillary cell carcinoma (KIRP) (HR = 3.3, Logrank p = 0.014), brain lower grade glioma (LGG) (HR = 2.1, Logrank p = 0.0033), liver hepatocellular carcinoma (LIHC) (HR = 2.2, Logrank p = 0.00079), mesothelioma (MESO) (HR = 4.4, Logrank p = 5.9e-05) (Fig. 1a and b and Fig. S1).